Sevenless Therapeutics ApS Financials, key figures and credit report
Gross profit - 197.1 kDKK FY 2025 +24.3% vs 2024
EBIT - 197.1 kDKK FY 2025 +24.3% vs 2024
Net debt - 435.3 kDKK FY 2025 +58.5% vs 2024
Quick ratio 36.8 FY 2025 -12.8 vs 2024
Income statement (kDKK)
2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| Gross profit | - 141.50 | - 691.74 | - 260.40 | - 197.10 |
| EBIT | - 141.50 | - 691.74 | - 260.40 | - 197.10 |
| Other financial income | 26.87 | 19.54 | 1.82 | 1.48 |
| Other financial expenses | -12.67 | -10.07 | -43.62 | -16.61 |
| Pre-tax profit | - 127.30 | - 682.27 | - 302.20 | - 212.23 |
| Income taxes | 302.69 | 578.81 | - 294.98 | 52.61 |
| Net earnings | 175.39 | - 103.46 | - 597.18 | - 159.62 |
Assets (kDKK)
2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Development expenditure | 3 821.86 | 9 142.01 | 10 496.74 | 11 386.06 |
| Intangible assets total | 3 821.86 | 9 142.01 | 10 496.74 | 11 386.06 |
| Tangible assets total | ||||
| Investments total | ||||
| Long term receivables total | ||||
| Inventories total | ||||
| Current amounts owed by group member comp. | 61.10 | 339.74 | 561.52 | |
| Current other receivables | 51.40 | 9.87 | 3.12 | 24.41 |
| Current deferred tax assets | 808.74 | 1 059.60 | 181.87 | |
| Short term receivables total | 860.14 | 1 130.57 | 524.73 | 585.92 |
| Cash and bank deposits | 4 024.69 | 1 743.97 | 1 049.01 | 435.31 |
| Cash and cash equivalents | 4 024.69 | 1 743.97 | 1 049.01 | 435.31 |
| Balance sheet total (assets) | 8 706.69 | 12 016.55 | 12 070.48 | 12 407.29 |
Equity and liabilities (kDKK)
2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 |
| Other reserves | 2 981.05 | 7 130.76 | 8 187.45 | 8 881.13 |
| Retained earnings | -2 981.05 | -6 955.37 | -8 115.52 | -9 406.37 |
| Profit of the financial year | 175.39 | - 103.46 | - 597.18 | - 159.62 |
| Shareholders equity total | 215.39 | 111.94 | - 485.24 | - 644.86 |
| Provisions | 506.05 | |||
| Non-current trade creditors | 7 075.75 | 10 532.28 | 11 060.34 | 11 613.35 |
| Non-current deferred tax liabilities | 986.84 | 1 463.68 | 1 411.07 | |
| Non-current liabilities total | 7 075.75 | 11 519.12 | 12 524.02 | 13 024.43 |
| Current trade creditors | 355.64 | 5.14 | ||
| Current owed to group member | 93.99 | |||
| Other non-interest bearing current liabilities | 815.50 | 29.85 | 31.70 | 22.59 |
| Current liabilities total | 909.49 | 385.49 | 31.70 | 27.73 |
| Balance sheet total (liabilities) | 8 706.69 | 12 016.55 | 12 070.48 | 12 407.29 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated